OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
Julio García-Villalba, Laura Hurtado‐Navarro, Alejandro Peñín‐Franch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

Showing 24 citing articles:

Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production
Cristina Molina‐López, Laura Hurtado‐Navarro, C. Garcı́a, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles
Naveen Kumar Mekala, Jayshil Trivedi, Priyanka Bhoj, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
Tobías Engel
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5410-5410
Open Access | Times Cited: 13

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
Sunny Malhotra, Laura Hurtado‐Navarro, Agustín Pappolla, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 13

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health
Elena Lo Presti, Domenico Nuzzo, Wael Al Mahmeed, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166559-166559
Open Access | Times Cited: 18

The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
Francesco Di Virgilio, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9465-9465
Open Access | Times Cited: 11

Animal Models for the Investigation of P2X7 Receptors
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8225-8225
Open Access | Times Cited: 9

A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19
Vitoria Guero Korb, Iago Carvalho Schultz, Liziane Raquel Beckenkamp, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7865-7865
Open Access | Times Cited: 8

TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease
Paloma Aivar, Carolina Bianchi, Caterina Di Lauro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10897-10897
Open Access | Times Cited: 7

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
Laura Hurtado‐Navarro, Ernesto José Cuenca‐Zamora, Lurdes Zamora, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101329-101329
Open Access | Times Cited: 7

Genetic Polymorphisms of P2RX7 but Not of ADORA2A Are Associated with the Severity of SARS-CoV-2 Infection
Jorge Lindo, Célia Nogueira, Rui Soares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6135-6135
Open Access | Times Cited: 1

The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury
Nayara Carvalho Barbosa, Fabiana Cristina‐Rodrigues, Jairo R. Temerozo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1

Melatonin’s Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective
Amanda Gollo Bertollo, Joana Bortolanza Dalazen, Joana Vitória Cassol, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Closed Access | Times Cited: 1

The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
Valentina Vultaggio-Poma, Juana María Sanz, Andrea Amico, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4

Purinergic signaling pathway in severe COVID-19
Lourdes Arruvito, Inés Sananez, Vanesa Seery, et al.
Current Opinion in Pharmacology (2023) Vol. 70, pp. 102379-102379
Open Access | Times Cited: 3

Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles
Naveen Kumar Mekala, Jayshil Trivedi, Priyanka Bhoj, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3

Purinergic signaling in the battlefield of viral infections
Nayara Carvalho-Barbosa, Julianna D. Zeidler, Luiz Eduardo Baggio Savio, et al.
Purinergic Signalling (2023)
Closed Access | Times Cited: 3

Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies
Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3005-3020
Closed Access | Times Cited: 2

Soluble P2X7 Receptor Plasma Levels in Obese Subjects before and after Weight Loss via Bariatric Surgery
Angelo Di Vincenzo, Marnie Granzotto, Andrea Graziani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16741-16741
Open Access | Times Cited: 2

Amyotrophic Lateral Sclerosis in Long-COVID Scenario and the Therapeutic Potential of the Purinergic System in Neuromodulation
Júlia Leão Batista Simões, Samantha Webler Eichler, Maria Luíza Raitz Siqueira, et al.
Brain Sciences (2024) Vol. 14, Iss. 2, pp. 180-180
Open Access

ATP-P2X7R pathway activation limits the Tfh cell compartment during pediatric RSV infection
Constanza Russo, Silvina Raiden, Silvia Algieri, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Pathogenic NLRP3 mutants forms constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production
Pablo Pelegrı́n, Cristina Molina‐López, Laura Hurtado‐Navarro, et al.
Research Square (Research Square) (2024)
Open Access

NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection
Consolato Sergi
Vaccines (2022) Vol. 10, Iss. 8, pp. 1307-1307
Open Access | Times Cited: 3

Page 1

Scroll to top